Corpus ID: 22861320

[Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].

@article{Yi2008ProphylacticEO,
  title={[Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].},
  author={Shan-hong Yi and G. Ye and Xiangwei Wang and Huan-Sheng Jin and Yuanning Zhang and Zhi-Lin Yan},
  journal={Ai zheng = Aizheng = Chinese journal of cancer},
  year={2008},
  volume={27 11},
  pages={
          1208-11
        }
}
  • Shan-hong Yi, G. Ye, +3 authors Zhi-Lin Yan
  • Published 2008
  • Medicine
  • Ai zheng = Aizheng = Chinese journal of cancer
    • BACKGROUND & OBJECTIVE Intravesical instillation is an important adjuvant therapy on preventing postoperative recurrence of superficial bladder transitional cell carcinoma, but the recurrence rate is still high. This study was to evaluate the prophylactic effect of intravesical instillation of hydroxycamptothecin (HYD) plus bacillus Calmette-Guerin (BCG) on postoperative recurrence of bladder transitional cell cancer. METHODS A total of 45 bladder cancer patients who underwent TURBT or… CONTINUE READING
    View on PubMed
    1 Citations
    One Citation
    Citation Type

    Citation Type

    Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis
    • 10

    References

    SHOWING 1-7 OF 7 REFERENCES
    15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach.
    • 21
    • PDF
    Impact of Intravesical Chemotherapy Versus BCG Immunotherapy on Recurrence of Superficial Transitional Cell Carcinoma of the Bladder: Metaanalytic Reevaluation
    • 66
    Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.
    • 34
    Interferon-alpha 2b instillation prophylaxis in superficial bladder cancer--a prospective, controlled three-armed trial. Project Group Bochum--Interferon and Superficial Bladder Cancer.
    • 17
    Twelve‐year follow up of a randomized prospective trial comparing bacillus Calmette‐Guerin and epirubicin as adjuvant therapy in superficial bladder cancer
    • C. W. Cheng, S. P. Chan, +8 authors M. Li
    • Medicine
    • International journal of urology : official journal of the Japanese Urological Association
    • 2005
    • 23
    Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    • 105
    Effect of intravesical instillation of mitomycin C therapy to prevent recurrence of superficial bladder cancer
    • Zhong Liu
    • 2000